Sanofi And Lexicon Fall Out Over Zynquista, As French Group Exits Diabetes Pact

 
• By Sten Stovall
  
Swift exit
Sanofi ‘walks’ from R&D Pact investigating Lexicon’s Zynquista in diabetes • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip